Immune signature-based risk stratification and prediction of immune checkpoint inhibitor’s efficacy for lung adenocarcinoma

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1432-0851

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Immune signature-based risk stratification and prediction of immune checkpoint inhibitor’s efficacy for lung adenocarcinoma ; volume:70 ; number:6 ; day:2 ; month:1 ; year:2021 ; pages:1705-1719 ; date:6.2021
Cancer immunology immunotherapy ; 70, Heft 6 (2.1.2021), 1705-1719, 6.2021

Creator: Yi, Ming
Li, Anping
Zhou, Linghui
Chu, Qian
Luo, Suxia
Wu, Kongming

Contributor: SpringerLink (Online service)

DOI: 10.1007/s00262-020-02817-z

URN: urn:nbn:de:101:1-2021091919014563016480

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:21 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Yi, Ming
Li, Anping
Zhou, Linghui
Chu, Qian
Luo, Suxia
Wu, Kongming
SpringerLink (Online service)

Other Objects (12)

Immune Checkpoint Inhibitor Rechallenge After Prior Immune Toxicity

Cancer immunotherapy beyond immune checkpoint inhibitors

Immune checkpoint inhibitor-related acral vasculitis

Signal detection of immune thrombocytopenia associated with immune checkpoint inhibitors

Safety of sequential immune checkpoint inhibitors after prior immune therapy

Thyroid disorders induced by immune checkpoint inhibitors

Immune Checkpoint Inhibitor Therapy in Neuroendocrine Tumors

Kutane Nebenwirkungen unter Immun-Checkpoint-Inhibitor-Therapie

Immune checkpoint inhibitors for multiple myeloma immunotherapy

Neurotoxicities associated with immune checkpoint inhibitor therapy

Cardiotoxicity risk factors with immune checkpoint inhibitors

Clinical Pharmacokinetics and Pharmacodynamics of Immune Checkpoint Inhibitors

Immune Checkpoint Inhibitor Rechallenge After Prior Immune Toxicity

Cancer immunotherapy beyond immune checkpoint inhibitors

Immune checkpoint inhibitor-related acral vasculitis

Signal detection of immune thrombocytopenia associated with immune checkpoint inhibitors

Safety of sequential immune checkpoint inhibitors after prior immune therapy

Thyroid disorders induced by immune checkpoint inhibitors

Immune Checkpoint Inhibitor Therapy in Neuroendocrine Tumors

Kutane Nebenwirkungen unter Immun-Checkpoint-Inhibitor-Therapie

Immune checkpoint inhibitors for multiple myeloma immunotherapy

Neurotoxicities associated with immune checkpoint inhibitor therapy

Cardiotoxicity risk factors with immune checkpoint inhibitors

Clinical Pharmacokinetics and Pharmacodynamics of Immune Checkpoint Inhibitors

Immune Checkpoint Inhibitor Rechallenge After Prior Immune Toxicity

Cancer immunotherapy beyond immune checkpoint inhibitors

Immune checkpoint inhibitor-related acral vasculitis

Signal detection of immune thrombocytopenia associated with immune checkpoint inhibitors

Safety of sequential immune checkpoint inhibitors after prior immune therapy

Thyroid disorders induced by immune checkpoint inhibitors

Immune Checkpoint Inhibitor Therapy in Neuroendocrine Tumors

Kutane Nebenwirkungen unter Immun-Checkpoint-Inhibitor-Therapie

Immune checkpoint inhibitors for multiple myeloma immunotherapy

Neurotoxicities associated with immune checkpoint inhibitor therapy

Cardiotoxicity risk factors with immune checkpoint inhibitors

Clinical Pharmacokinetics and Pharmacodynamics of Immune Checkpoint Inhibitors

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Immune signature-based risk stratification and prediction of immune checkpoint inhibitor’s efficacy for lung adenocarcinoma

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Immune Checkpoint Inhibitor Rechallenge After Prior Immune Toxicity

Cancer immunotherapy beyond immune checkpoint inhibitors

Immune checkpoint inhibitor-related acral vasculitis

Signal detection of immune thrombocytopenia associated with immune checkpoint inhibitors

Safety of sequential immune checkpoint inhibitors after prior immune therapy

Thyroid disorders induced by immune checkpoint inhibitors

Immune Checkpoint Inhibitor Therapy in Neuroendocrine Tumors

Kutane Nebenwirkungen unter Immun-Checkpoint-Inhibitor-Therapie

Immune checkpoint inhibitors for multiple myeloma immunotherapy

Neurotoxicities associated with immune checkpoint inhibitor therapy

Cardiotoxicity risk factors with immune checkpoint inhibitors

Clinical Pharmacokinetics and Pharmacodynamics of Immune Checkpoint Inhibitors

Immune Checkpoint Inhibitor Rechallenge After Prior Immune Toxicity

Cancer immunotherapy beyond immune checkpoint inhibitors

Immune checkpoint inhibitor-related acral vasculitis

Signal detection of immune thrombocytopenia associated with immune checkpoint inhibitors

Safety of sequential immune checkpoint inhibitors after prior immune therapy

Thyroid disorders induced by immune checkpoint inhibitors

Immune Checkpoint Inhibitor Therapy in Neuroendocrine Tumors

Kutane Nebenwirkungen unter Immun-Checkpoint-Inhibitor-Therapie

Immune checkpoint inhibitors for multiple myeloma immunotherapy

Neurotoxicities associated with immune checkpoint inhibitor therapy

Cardiotoxicity risk factors with immune checkpoint inhibitors

Clinical Pharmacokinetics and Pharmacodynamics of Immune Checkpoint Inhibitors

Immune Checkpoint Inhibitor Rechallenge After Prior Immune Toxicity

Cancer immunotherapy beyond immune checkpoint inhibitors

Immune checkpoint inhibitor-related acral vasculitis

Signal detection of immune thrombocytopenia associated with immune checkpoint inhibitors

Safety of sequential immune checkpoint inhibitors after prior immune therapy

Thyroid disorders induced by immune checkpoint inhibitors

Immune Checkpoint Inhibitor Therapy in Neuroendocrine Tumors

Kutane Nebenwirkungen unter Immun-Checkpoint-Inhibitor-Therapie

Immune checkpoint inhibitors for multiple myeloma immunotherapy

Neurotoxicities associated with immune checkpoint inhibitor therapy

Cardiotoxicity risk factors with immune checkpoint inhibitors

Clinical Pharmacokinetics and Pharmacodynamics of Immune Checkpoint Inhibitors

Related objects

Reset password